Answer
It is licensed as monotherapy for chronic lymphocytic leukaemia and for relapsed or refractory mantle cell lymphoma previously treated with a BTK inhibitor.
Sources for this answer
- Jaypirca 50mg, 100mg film-coated tabletsemc · SmPC Current selected SmPC · Version 3